Who has invested in Atea Pharmaceuticals?

Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group are named among the investors backing Atea Pharmaceuticals.

Atea Pharmaceuticals Funding: $500M Raised, IPO

Atea Pharmaceuticals funding overview

Atea Pharmaceuticals is based in Boston, MA. Atea Pharmaceuticals has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO. Investors on record include Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group and 1 others. 7 distinct backers are named across the disclosed rounds.

Atea Pharmaceuticals at a glance

Total raised: $500M
Latest round: IPO
Headquarters: Boston, MA
Notable investors: Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group, Fidelity Management & Research Company

Frequently asked about Atea Pharmaceuticals funding

How much has Atea Pharmaceuticals raised?: Atea Pharmaceuticals has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Atea Pharmaceuticals?: Bain Capital Life Sciences, Adage Capital, RA Capital, Redmile Group, BlackRock, Vanguard Group are named among the investors backing Atea Pharmaceuticals.
What was the latest Atea Pharmaceuticals funding round?: The most recent disclosed round is an IPO.
Where is Atea Pharmaceuticals based?: Atea Pharmaceuticals is based in Boston, MA.

Round data for Atea Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

Atea Pharmaceuticals Funding: $500M Raised, IPO

Atea Pharmaceuticals funding overview

Atea Pharmaceuticals at a glance

Frequently asked about Atea Pharmaceuticals funding

Companies related to Atea Pharmaceuticals (35)

Browse related funding lists (7)